• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-Abl-p38α信号通路在MPTP诱导的神经元死亡中起重要作用。

c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.

作者信息

Wu R, Chen H, Ma J, He Q, Huang Q, Liu Q, Li M, Yuan Z

机构信息

State Key Laboratory of Brain and Cognitive Sciences, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China.

College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Cell Death Differ. 2016 Mar;23(3):542-52. doi: 10.1038/cdd.2015.135. Epub 2015 Oct 30.

DOI:10.1038/cdd.2015.135
PMID:26517532
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5072446/
Abstract

Oxidative stress is a major cause of sporadic Parkinson's disease (PD). Here, we demonstrated that c-Abl plays an important role in oxidative stress-induced neuronal cell death. C-Abl, a nonreceptor tyrosine kinase, was activated in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine hydrochloride (MPTP)-induced acute PD model. Conditional knockout of c-Abl in neurons or treatment of mice with STI571, a c-Abl family kinase inhibitor, reduced the loss of dopaminergic neurons and ameliorated the locomotive defects induced by short-term MPTP treatment. By combining the SILAC (stable isotope labeling with amino acids in cell culture) technique with other biochemical methods, we identified p38α as a major substrate of c-Abl both in vitro and in vivo and c-Abl-mediated phosphorylation is critical for the dimerization of p38α. Furthermore, p38α inhibition mitigated the MPTP-induced loss of dopaminergic neurons. Taken together, these data suggested that c-Abl-p38α signaling may represent a therapeutic target for PD.

摘要

氧化应激是散发性帕金森病(PD)的主要病因。在此,我们证明了c-Abl在氧化应激诱导的神经元细胞死亡中起重要作用。c-Abl是一种非受体酪氨酸激酶,在1-甲基-4-苯基-1,2,3,6-四氢吡啶盐酸盐(MPTP)诱导的急性PD模型中被激活。在神经元中条件性敲除c-Abl或用c-Abl家族激酶抑制剂STI571处理小鼠,可减少多巴胺能神经元的损失,并改善短期MPTP处理诱导的运动缺陷。通过将细胞培养中氨基酸稳定同位素标记(SILAC)技术与其他生化方法相结合,我们在体外和体内确定p38α是c-Abl的主要底物,且c-Abl介导的磷酸化对p38α的二聚化至关重要。此外,抑制p38α可减轻MPTP诱导的多巴胺能神经元损失。综上所述,这些数据表明c-Abl-p38α信号通路可能是PD的一个治疗靶点。

相似文献

1
c-Abl-p38α signaling plays an important role in MPTP-induced neuronal death.c-Abl-p38α信号通路在MPTP诱导的神经元死亡中起重要作用。
Cell Death Differ. 2016 Mar;23(3):542-52. doi: 10.1038/cdd.2015.135. Epub 2015 Oct 30.
2
Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model.新型穿透血脑屏障的 C-Abl 抑制剂在帕金森病小鼠模型中的神经保护作用。
PLoS One. 2013 May 31;8(5):e65129. doi: 10.1371/journal.pone.0065129. Print 2013.
3
Role of c-Abl-GSK3β Signaling in MPP+-Induced Autophagy-Lysosomal Dysfunction.c-Abl-GSK3β 信号通路在 MPP+诱导的自噬溶酶体功能障碍中的作用。
Toxicol Sci. 2018 Sep 1;165(1):232-243. doi: 10.1093/toxsci/kfy155.
4
The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.c-Abl 抑制剂尼罗替尼可保护帕金森病动物模型中的多巴胺能神经元。
Sci Rep. 2014 May 2;4:4874. doi: 10.1038/srep04874.
5
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.c-Abl 蛋白酪氨酸激酶的磷酸化抑制了 parkin 的泛素化及其保护功能。
Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16691-6. doi: 10.1073/pnas.1006083107. Epub 2010 Sep 7.
6
JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.JNK 抑制剂通过降低 MPTP 亚急性帕金森病小鼠模型中 COX-2 的表达来保护多巴胺能神经元。
J Neurol Sci. 2009 Oct 15;285(1-2):172-7. doi: 10.1016/j.jns.2009.06.034. Epub 2009 Jul 14.
7
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.通过 c-Abl 介导的酪氨酸磷酸化调控 parkin 功能:对帕金森病的影响。
J Neurosci. 2011 Jan 5;31(1):157-63. doi: 10.1523/JNEUROSCI.1833-10.2011.
8
CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.CEP-1347/KT-7515,一种c-jun氨基末端激酶激活抑制剂,可减轻1-甲基-4-苯基四氢吡啶在体内介导的黑质纹状体多巴胺能神经元损失。
J Pharmacol Exp Ther. 1999 Feb;288(2):421-7.
9
c-Abl-p38 signaling pathway mediates dopamine neuron loss in trigeminal neuralgia.c-Abl-p38 信号通路介导三叉神经痛中多巴胺神经元的丢失。
Mol Pain. 2020 Jan-Dec;16:1744806920930855. doi: 10.1177/1744806920930855.
10
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.在MPTP处理的帕金森病小鼠模型和碘代MPP处理的MN9D细胞中,miR-124的下调调节了钙蛋白酶/细胞周期蛋白依赖性激酶5(calpain/cdk5)信号通路蛋白的表达。
Neuroscience. 2014 Jul 11;272:167-79. doi: 10.1016/j.neuroscience.2014.04.039. Epub 2014 Apr 30.

引用本文的文献

1
Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024).美国食品药品监督管理局(FDA)批准的用于治疗神经疾病的激酶抑制剂的实验和临床测试(2024年更新)
Explor Drug Sci. 2025;3. doi: 10.37349/eds.2025.1008116. Epub 2025 Jul 1.
2
Modulation of Peripheral Mast Cell and Brain Microglia Axis via Kinase Inhibition.通过激酶抑制调节外周肥大细胞和脑小胶质细胞轴
Metabolites. 2025 Mar 11;15(3):194. doi: 10.3390/metabo15030194.
3
Potential association between COVID-19 and neurological disorders: analysis of common genes and therapeutics.新型冠状病毒肺炎与神经系统疾病之间的潜在关联:常见基因与治疗方法分析
Front Neurol. 2024 Oct 14;15:1417183. doi: 10.3389/fneur.2024.1417183. eCollection 2024.
4
Shisandra Decoction Alleviates Parkinson's Disease Symptoms in a Mouse Model Through PI3K/AKT/mTOR Signalling Pathway.五味子汤通过PI3K/AKT/mTOR信号通路减轻小鼠模型中的帕金森病症状。
Neuropsychiatr Dis Treat. 2024 Oct 23;20:2011-2027. doi: 10.2147/NDT.S476969. eCollection 2024.
5
An update on novel and emerging therapeutic targets in Parkinson's disease.帕金森病中新的和新兴治疗靶点的研究进展。
Metab Brain Dis. 2024 Aug;39(6):1213-1225. doi: 10.1007/s11011-024-01390-z. Epub 2024 Jul 27.
6
Neuroprotective Activity of a Non-Covalent Imatinib+TP10 Conjugate in HT-22 Neuronal Cells In Vitro.非共价伊马替尼+TP10缀合物在体外HT-22神经元细胞中的神经保护活性
Pharmaceutics. 2024 Jun 7;16(6):778. doi: 10.3390/pharmaceutics16060778.
7
E3 ubiquitin ligase TRIM31 alleviates dopaminergic neurodegeneration by promoting proteasomal degradation of VDAC1 in Parkinson's Disease model.E3 泛素连接酶 TRIM31 通过促进帕金森病模型中 VDAC1 的蛋白酶体降解来减轻多巴胺能神经元变性。
Cell Death Differ. 2024 Nov;31(11):1410-1421. doi: 10.1038/s41418-024-01334-1. Epub 2024 Jun 25.
8
The autophagy-lysosome pathway: a potential target in the chemical and gene therapeutic strategies for Parkinson's disease.自噬-溶酶体途径:帕金森病化学治疗和基因治疗策略中的一个潜在靶点。
Neural Regen Res. 2025 Jan 1;20(1):139-158. doi: 10.4103/NRR.NRR-D-23-01195. Epub 2024 Jan 31.
9
Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease.谷氨酸受体和 C-ABL 抑制剂:帕金森病的一种新治疗方法。
Cent Nerv Syst Agents Med Chem. 2024;24(1):22-44. doi: 10.2174/0118715249268627231206115942.
10
CNS-Active p38α MAPK Inhibitors for the Management of Neuroinflammatory Diseases: Medicinal Chemical Properties and Therapeutic Capabilities.CNS 活性 p38α MAPK 抑制剂用于神经炎症性疾病的治疗:药物化学性质和治疗能力。
Mol Neurobiol. 2024 Jul;61(7):3911-3933. doi: 10.1007/s12035-023-03829-3. Epub 2023 Dec 2.

本文引用的文献

1
The c-Abl inhibitor, nilotinib, protects dopaminergic neurons in a preclinical animal model of Parkinson's disease.c-Abl 抑制剂尼罗替尼可保护帕金森病动物模型中的多巴胺能神经元。
Sci Rep. 2014 May 2;4:4874. doi: 10.1038/srep04874.
2
c-Abl phosphorylates α-synuclein and regulates its degradation: implication for α-synuclein clearance and contribution to the pathogenesis of Parkinson's disease.c-Abl使α-突触核蛋白磷酸化并调节其降解:对α-突触核蛋白清除的影响以及对帕金森病发病机制的作用。
Hum Mol Genet. 2014 Jun 1;23(11):2858-79. doi: 10.1093/hmg/ddt674. Epub 2014 Jan 9.
3
Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model.新型穿透血脑屏障的 C-Abl 抑制剂在帕金森病小鼠模型中的神经保护作用。
PLoS One. 2013 May 31;8(5):e65129. doi: 10.1371/journal.pone.0065129. Print 2013.
4
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of α-synuclein in Parkinson's disease models.尼洛替尼通过自噬降解α-突触核蛋白逆转帕金森病模型中多巴胺神经元的丢失并改善运动行为。
Hum Mol Genet. 2013 Aug 15;22(16):3315-28. doi: 10.1093/hmg/ddt192. Epub 2013 May 10.
5
Regulation of neuronal cell death by c-Abl-Hippo/MST2 signaling pathway.c-Abl-Hippo/MST2 信号通路对神经元细胞死亡的调控。
PLoS One. 2012;7(5):e36562. doi: 10.1371/journal.pone.0036562. Epub 2012 May 9.
6
c-Abl in neurodegenerative disease.c-Abl 在神经退行性疾病中的作用。
J Mol Neurosci. 2011 Nov;45(3):445-52. doi: 10.1007/s12031-011-9588-1. Epub 2011 Jul 5.
7
The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death.c-Abl-MST1 信号通路介导氧化应激诱导的神经元细胞死亡。
J Neurosci. 2011 Jun 29;31(26):9611-9. doi: 10.1523/JNEUROSCI.0035-11.2011.
8
p38α MAP kinase dimers with swapped activation segments and a novel catalytic loop conformation.p38α MAP 激酶二聚体具有交换的激活片段和新颖的催化环构象。
J Mol Biol. 2011 Aug 12;411(2):474-85. doi: 10.1016/j.jmb.2011.06.013. Epub 2011 Jun 15.
9
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease.通过 c-Abl 介导的酪氨酸磷酸化调控 parkin 功能:对帕金森病的影响。
J Neurosci. 2011 Jan 5;31(1):157-63. doi: 10.1523/JNEUROSCI.1833-10.2011.
10
Phosphorylation by the c-Abl protein tyrosine kinase inhibits parkin's ubiquitination and protective function.c-Abl 蛋白酪氨酸激酶的磷酸化抑制了 parkin 的泛素化及其保护功能。
Proc Natl Acad Sci U S A. 2010 Sep 21;107(38):16691-6. doi: 10.1073/pnas.1006083107. Epub 2010 Sep 7.